- Home
- TMHC vs RVMD Comparison
TMHC vs RVMD Comparison
Compare TMHC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMHC | RVMD |
|---|---|---|
| Founded | 1936 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 7.5B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TMHC | RVMD |
|---|---|---|
| Price | $62.27 | $78.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 18 |
| Target Price | $76.83 | ★ $77.11 |
| AVG Volume (30 Days) | 846.6K | ★ 2.2M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.21 | N/A |
| EPS | ★ 8.31 | N/A |
| Revenue | ★ $8,378,329,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $714.50 |
| P/E Ratio | $7.53 | ★ N/A |
| Revenue Growth | ★ 6.98 | N/A |
| 52 Week Low | $51.90 | $29.17 |
| 52 Week High | $72.50 | $81.49 |
Technical Indicators
Market Signals| Indicator | TMHC | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 73.68 |
| Support Level | $60.06 | $77.54 |
| Resistance Level | $63.42 | $81.49 |
| Average True Range (ATR) | 1.60 | 2.51 |
| MACD | 0.10 | -0.48 |
| Stochastic Oscillator | 55.44 | 75.46 |
Price Performance
Historical ComparisonAbout TMHC Taylor Morrison Home Corporation
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.